NEW ORLEANS, June 12 /PRNewswire-FirstCall/ -- Siemens Healthcare
(http://www.siemens.com/healthcare) highlights innovative solutions in molecular
imaging at the 2008 Society of Nuclear Medicine (SNM) Scientific Sessions
in New Orleans, June 14-18. The Siemens booth (#731) will feature its
newest technology, HD-PET, as well as new features in SPECT imaging and
imaging biomarker developments.

Siemens HD-PET is the world's first and only high-definition PET
technology to offer consistently sharper and clearly defined images across
the entire field of view. The clarity achieved by HD-PET is the result of a
unique and proprietary technology that optimizes the elements of image
uniformity, resolution and contrast -- that together change the whole
picture.

The improved resolution enables physicians to clearly visualize small
lesions from the center to the edges of the field of view.

Siemens showcases the experiences of the early adopters of HD-PET
technology at the SNM 2008.

Symbia(R) E -- Simply Evolutionary

Siemens Symbia family of imagers is the highlight of the SNM
exhibition, featuring Symbia E showcased for the first time in the United
States. Symbia E addresses the needs of the cost-conscious consumer by
redefining the quality of cost-efficient molecular imaging. The newest
addition to the Symbia family of SPECT and SPECT-CT imaging systems, Symbia
E provides users with a high-quality SPECT imager that can lead to improved
clinical confidence, reliability and versatility.

"As the leader in molecular imaging innovations, Siemens introduced
Symbia E, representing the first product designed to address the post-DRA
environment, providing a cost-efficient, yet high-quality solution," said
Michael Reitermann, chief executive officer, Molecular Imaging, Siemens
Medical Solutions USA, Inc. The new Symbia E is based on the success of
Siemens Symbia family of imagers, taking Symbia's detector technology and
making it available on Symbia E.

A new generation of HD detectors is the key innovation leading to
best-in-class performance and reliability. Using these detectors, where
Siemens achieved an 85 percent reduction in wiring and a 75 percent
reduction in components, the overall reliability of the product is
significantly increased. Symbia E is primed to be the newest general
imaging SPECT and cardiac SPECT workhorse for customers who require a quick
return on their investment; especially important in the post-DRA
environment.

Research Breakthroughs in Imaging Biomarkers

While currently the largest distributor of PET radiopharmaceuticals in
the U.S. and aggressively expanding internationally into countries and
regions, such as India, the United Kingdom, Korea and Australia, Siemens is
also making inroads into developing new imaging biomarkers that may be used
in the future. Siemens Molecular Imaging Biomarker Research facility in Los
Angeles has recently submitted an Investigational New Drug (IND)
application for a new imaging agent that will help with imaging hypoxic
tumors, which may be resistant to standard treatment involving
chemotherapy. This type of imaging biomarker may be valuable in managing
the treatment options for cancer patients.

"By investing into the research and development of new
radiopharmaceuticals and expanding our distribution network, Siemens is
helping to improve access to PET technology, an increasingly essential
component to oncological, cardiac and neurological treatments," Reitermann
said.

Siemens also recently announced that the National Cancer Institute has
filed a cross-reference letter to a Type II Drug Master File that Siemens
submitted to the U.S. Food and Drug Administration for its investigational
3'Deoxy-3'[18F] Fluorothymidine (F-18 FLT) imaging biomarker. The cross
reference allows F-18 FLT to be produced by Siemens/PETNET and used by any
principle investigator in an NCI multi-center clinical trial. In addition,
the imaging biomarker will be available to independent investigators if
they receive NCI approval. F-18 FLT is produced by Siemens Molecular
Imaging Biomarker Research and PETNET Solutions, subsidiaries of Siemens
Medical Solutions USA, Inc. The imaging biomarker has been used in studies
monitoring the proliferative activity of cancer cells and it is currently
being used in Phase-I clinical trials at several research sites.

MI-University -- Tools for the Trade

Tying it all together, Siemens Molecular Imaging (MI) University
provides a substantive training resource for Siemens' customers. Today's
molecular imaging professionals require continuous education, training and
the ability to share results. Designed to be used by the interpreting
physician, referring physician and technologist, MI University demonstrates
the benefits of hybrid PET-CT and SPECT-CT systems, including when and how
hybrid imaging influences patient management, through access to valuable
clinical data and detailed case studies; video lectures; product
information; and a tool for information exchange among peers.
(https://www.mi-lifenet.com/miudemo/)

About Siemens Healthcare

Siemens Healthcare is one of the world's largest suppliers to the
healthcare industry. The company is a renowned medical solutions provider
with core competence and innovative strength in diagnostic and therapeutic
technologies as well as in knowledge engineering, including information
technology and system integration. With its laboratory diagnostics
acquisitions, Siemens Healthcare is the first fully integrated diagnostics
company, bringing together imaging and lab diagnostics, therapy, and
healthcare information technology solutions, supplemented by consulting and
support services. Siemens Healthcare delivers solutions across the entire
continuum of care -- from prevention and early detection, to diagnosis,
therapy and care. Additionally, Siemens is the global market leader in
innovative hearing instruments. The company employs more than 49,000 people
worldwide and operates in 130 countries. In the fiscal year 2007 (Sept.
30), Siemens Healthcare reported sales of euro 9.85 billion, orders of euro
10.27 billion, and group profit of euro 1.32 billion. Further information
can be found by visiting http://www.siemens.com/healthcare.

(Date:10/13/2017)... ... 2017 , ... The International Association of Eating Disorders Professionals ... the field of eating disorders, announces the opening of early registration for the ... at the Omni Resort at ChampionsGate. , The annual iaedp™ Symposium ...

(Date:10/13/2017)... ... 2017 , ... Apple Rehab Shelton Lakes , which specializes in the ... facility as part of a disaster drill on October 3rd. , Apple Rehab participated ... Emergency Manager, as well as the Connecticut Long Term Care Mutual Aid Plan ...

(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains ... possible to save lost souls in the Philippines. “The Journey: From the Mountains to ... dedicated teacher of the Bible. She has taught all ages and currently teaches a ...

(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and fastest ... to open a flagship location in Covington, LA at 401 N. U.S. Highway 190, ... next to Office Depot in the Holiday Square shopping center. Its location allows it ...

(Date:10/12/2017)... 2017 West Pharmaceutical Services, Inc. ... injectable drug administration, today announced that it will release ... Thursday, October 26, 2017, and will follow with a ... at 9:00 a.m. Eastern Time. To participate on the ... conference ID is 94093362. ...

(Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...

(Date:10/4/2017)... -- According to the Centers for Disease Control and Prevention (CDC), influenza ... Care is helping communities across Massachusetts , ... no-cost* flu shots through the end of the month. *Some ... ... flu shot is by the end of October, according to the Centers ...